Monsanto Co: (NYSE: MON)

$108.31

-0.07 (-0.07%)

Volume 2,083,796

May 20 04:03 PM ET

Zacks Rank: 2-Buy

 
#2
 
 
 

Full Company Report

Get Full Company Report for:

Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.

General Information

MONSANTO CO-NEW
800 N LINDBERGH BLVD
ST LOUIS, MO 63167
Phone: 3146941000
Fax: 314-694-1057
Web: http://www.monsanto.com
Email: investor.relations@monsanto.com

Industry AGRICULTURE/PRODUCTS
Sector Basic Materials
Fiscal Year End August
Last Reported Quarter 02/28/2013
Next EPS Date 06/26/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 108.38
52 Week High 109.33
52 Week Low 69.87
Beta 0.94
20 Day Moving Average 1,885,961.00
Target Price Consensus 113.46

% Price Change

4 Week 6.13
12 Week 9.80
YTD 13.76

Share Information

Shares Outstanding (millions) 533.84
Market Capitalization (millions) 57,857.69
Short Ratio 1.54
Last Split Date 07/31/06

MON

% Price Change Relative to S&P 500

4 Week -1.88
12 Week -1.07
YTD -0.28

Dividend Information

Dividend Yield 1.38%
Annual Dividend $1.50
Payout Ratio 0.33
Change in Payout Ratio 0.00
Last Dividend Payout / Amount 04/03/2013 / $0.38

EPS Information

Current Quarter EPS Consensus Estimate 1.70
Current Year EPS Consensus Estimate 4.58
Estimated Long-Term EPS Growth Rate 12.70
Next EPS Report Date 06/26/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 1.78
30 Days Ago 1.95
60 Days Ago 1.89
90 Days Ago 1.78

Fundamental Ratios

P/E

Current FY Estimate 23.65
Trailing 12 Months 23.87
PEG Ratio 1.87

Price Ratios

Price/Book 4.31
Price/Cash Flow 22.15
Price / Sales 3.93

Current Ratio

02-28-13 2.45
11-30-12 1.96
08-31-12 2.29

Net Margin

02-28-13 17.16
11-30-12 16.11
08-31-12 15.13

Inventory Turnover

02-28-13 2.34
11-30-12 2.26
08-31-12 2.28

EPS Growth

vs. Previous Year 19.74%
vs. Previous Quarter 340.32%
   

ROE

02-28-13 19.46
11-30-12 17.94
08-31-12 16.69

Quick Ratio

02-28-13 1.79
11-30-12 1.38
08-31-12 1.62

Pre-Tax Margin

02-28-13 24.32
11-30-12 23.17
08-31-12 22.13

Debt-to-Equity

02-28-13 0.15
11-30-12 0.16
08-31-12 0.17

Sales Growth

vs. Previous Year 15.25%
vs. Previous Quarter 86.19%
   

ROA

02-28-13 11.56
11-30-12 10.56
08-31-12 9.82

Operating Margin

02-28-13 16.63
11-30-12 15.71
08-31-12 14.77

Book Value

02-28-13 25.16
11-30-12 23.32
08-31-12 22.58

Debt to Capital

02-28-13 13.24
11-30-12 14.15
08-31-12 14.48

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.